Molecular and Systems Pharmacology (GDBBS)

Percentages are rounded to whole numbers and do not always add to 100.

MD/PhD students are excluded from the Admissions entries, included in the enrollment entries (when they are enrolled in the LGS, as opposed to in the SOM), included in the number of degrees awarded (PhD only), and excluded from the time to degree and completion percentage entries.

PhD Program Data

Fall 2017

Fall 2016

5 Year Average

PhD Admissions

Number of applications 97 116 97
Number of admissions offers (Selectivity) 13 (13%) 14 (12%) 14 (15%)
Number of new doctoral students (Yield) 10 (77%) 8 (57%) 7 (52%)

PhD Enrollment

Total enrollment 44 40 40
Female 49% 45% 45%
Male 51% 55% 55%
International 7% 8% 8%
U.S. citizen or permanent resident 93% 93% 92%

PhD Enrollment, U.S. Citizen or
Permanent Resident, by Race

Black or African American 8% 8% 6%
Asian 8% 5% 5%
Hispanic of any race 18% 16% 14%
American Indian or Alaska Native
Native Hawaiian or Other Pacific Islander 3% 2%
White 65% 59% 61%
Two or more races
Not indicated 3% 8% 12%

PhD Degrees

2016-17

2015-16

5 Year Average

Number of degrees awarded 8 8 7
Median years to PhD 5.5 5.9 5.9
Average adjusted years to PhD 5.6 6.1 6.1
Percent of students who entered between
2005-06 and 2009-10, and completed
the PhD as of August 31, 2017
80

Understand the Data

Click the button for explanations of the data shown on the program data pages. 

Explanatory Notes